OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
DGWG56

Delta Giri Wacana Tbk PT

Agricultural ChemicalsVerified

Delta Giri Wacana Tbk PT has a debt-to-equity ratio of 1.42, indicating a moderate reliance on debt financing, which is in line with the typical capital structure of companies in the agricultural chemicals industry. The company's liquidity position is assessed as medium, with a current ratio of 1.07, suggesting it has just enough current assets to cover its current liabilities. However, the company has no cash and equivalents and a negative net cash position after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, the company's return on equity is 2.32%, and its return on assets is 0.61%, both of which are below the industry median for agricultural chemicals firms. This suggests that the company is underperforming in terms of generating returns for shareholders and utilizing its assets efficiently. The operating margin is 5.57%, and the net profit margin is 2.03%, which are also below the industry average, indicating that the company is facing cost pressures or pricing challenges. The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no significant geographic diversification. This lack of diversification increases the company's exposure to regional economic and regulatory risks. The company's operations are primarily based in Indonesia, and it does not report any material revenue from international markets. Looking at the company's growth trajectory, there is no indication of significant revenue growth in the near term. The company's capital expenditures are negative, suggesting a reduction in investment in new projects or capacity expansion. This could be a sign of operational retrenchment or a strategic shift in focus. The company's free cash flow is also negative, indicating that it is not generating sufficient cash from operations to fund its capital expenditures. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The negative net cash position and the absence of cash and equivalents increase the company's vulnerability to short-term financial stress. However, the company has not issued any new shares recently, and there is no indication of imminent dilution. The company's debt structure is primarily long-term, which provides some stability in its capital structure. Recent events and disclosures indicate that the company has not filed any material regulatory or legal proceedings in the past year. The company's latest financial report does not mention any significant changes in management, strategic direction, or major business developments. The company's financial performance has been stable, but there are no signs of improvement in its profitability or liquidity position.

30-day price · DGWG-18.00 (-4.9%)
Low$346.00High$420.00Close$352.00As of11 May, 00:00 UTC
Profile
CompanyDelta Giri Wacana Tbk PT
TickerDGWG.JK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Delta Giri Wacana Tbk PT is an agricultural chemicals company that produces and distributes fertilizers and other agrochemical products, primarily generating revenue through the sale of these products to farmers and agricultural businesses.

Classification. Delta Giri Wacana Tbk PT is classified under the Basic Materials economic sector, within the Chemicals business sector and the Agricultural Chemicals industry, with a classification confidence of 0.92.

Delta Giri Wacana Tbk PT has a debt-to-equity ratio of 1.42, indicating a moderate reliance on debt financing, which is in line with the typical capital structure of companies in the agricultural chemicals industry. The company's liquidity position is assessed as medium, with a current ratio of 1.07, suggesting it has just enough current assets to cover its current liabilities. However, the company has no cash and equivalents and a negative net cash position after subtracting total debt, which raises concerns about its short-term liquidity. In terms of profitability, the company's return on equity is 2.32%, and its return on assets is 0.61%, both of which are below the industry median for agricultural chemicals firms. This suggests that the company is underperforming in terms of generating returns for shareholders and utilizing its assets efficiently. The operating margin is 5.57%, and the net profit margin is 2.03%, which are also below the industry average, indicating that the company is facing cost pressures or pricing challenges. The company's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no significant geographic diversification. This lack of diversification increases the company's exposure to regional economic and regulatory risks. The company's operations are primarily based in Indonesia, and it does not report any material revenue from international markets. Looking at the company's growth trajectory, there is no indication of significant revenue growth in the near term. The company's capital expenditures are negative, suggesting a reduction in investment in new projects or capacity expansion. This could be a sign of operational retrenchment or a strategic shift in focus. The company's free cash flow is also negative, indicating that it is not generating sufficient cash from operations to fund its capital expenditures. The company's risk profile is characterized by medium liquidity risk and low dilution risk. The negative net cash position and the absence of cash and equivalents increase the company's vulnerability to short-term financial stress. However, the company has not issued any new shares recently, and there is no indication of imminent dilution. The company's debt structure is primarily long-term, which provides some stability in its capital structure. Recent events and disclosures indicate that the company has not filed any material regulatory or legal proceedings in the past year. The company's latest financial report does not mention any significant changes in management, strategic direction, or major business developments. The company's financial performance has been stable, but there are no signs of improvement in its profitability or liquidity position.
Key takeaways
  • Delta Giri Wacana Tbk PT has a debt-to-equity ratio of 1.42, indicating a moderate reliance on debt financing.
  • The company's return on equity is 2.32%, and its return on assets is 0.61%, both of which are below the industry median.
  • The company's revenue is concentrated in a single business segment, with no significant geographic diversification.
  • The company's capital expenditures are negative, suggesting a reduction in investment in new projects or capacity expansion.
  • The company's liquidity position is assessed as medium, with a current ratio of 1.07 and no cash and equivalents.
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$753.62B
Gross profit$199.59B
Operating income$41.97B
Net income$15.30B
R&D
SG&A
D&A
SBC
Operating cash flow-$17.34B
CapEx-$91.16B
Free cash flow-$37.50B
Total assets$2.52T
Total liabilities$1.86T
Total equity$658.78B
Cash & equivalents$0.00
Long-term debt$934.20B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$1.38T$115.74B$81.04B$107.05B
FY-3$1.69T$205.32B$142.30B$136.46B
FY-2$3.04T$104.47B$15.24B-$16.49B
FY-1$3.37T$278.82B$178.69B-$239.10B
FY0$4.15T$401.65B$218.85B$75.76B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$991.33B$280.19B$0.00
FY-3$2.19T$521.83B$0.00
FY-2$2.42T$626.48B$15.00B
FY-1$2.91T$758.46B$40.0M
FY0$4.04T$1.06T$0.00
PeriodOCFCapExFCFSBC
FY-4-$81.01B-$3.12B$107.05B
FY-3$78.92B-$36.35B$136.46B
FY-2$129.78B-$83.90B-$16.49B
FY-1$129.48B-$163.37B-$239.10B
FY0-$24.96B-$99.09B$75.76B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$753.62B$41.97B$15.30B-$37.50B
FQ-6$926.80B$64.12B$61.45B$88.71B
FQ-5$961.43B$126.73B$85.51B$9.96B
FQ-4$803.14B$57.28B$25.89B$29.45B
FQ-3$846.57B$49.97B$26.27B-$18.06B
FQ-2$995.57B$104.59B$51.16B$57.21B
FQ-1$1.50T$189.81B$115.53B$67.10B
FQ0$1.10T$97.94B$49.38B$47.93B
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$2.52T$658.78B$0.00
FQ-6
FQ-5$2.91T$758.46B$40.0M
FQ-4$2.98T$978.20B$40.0M
FQ-3$3.15T$947.55B$40.0M
FQ-2$3.49T$998.72B$0.00
FQ-1$4.04T$1.06T$0.00
FQ0$3.99T$1.11T
PeriodOCFCapExFCFSBC
FQ-7-$17.34B-$91.16B-$37.50B
FQ-6$68.28B-$76.40B$88.71B
FQ-5$129.48B-$163.37B$9.96B
FQ-4-$253.35B-$7.87B$29.45B
FQ-3-$87.15B-$71.33B-$18.06B
FQ-2-$170.25B-$81.33B$57.21B
FQ-1-$24.96B-$99.09B$67.10B
FQ0-$132.71B-$16.64B$47.93B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$658.78B
Net cash-$934.20B
Current ratio1.1
Debt/Equity1.4
ROA0.6%
ROE2.3%
Cash conversion-1.1%
CapEx/Revenue-12.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricDGWGActivity
Op margin5.6%5.5% medp25 -0.0% · p75 10.8%above median
Net margin2.0%4.1% medp25 0.1% · p75 8.8%below median
Gross margin26.5%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-12.1%-6.2% medp25 -13.4% · p75 -2.6%below median
Debt / equity142.0%37.1% medp25 10.3% · p75 82.0%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:48 UTC#8f2816d6
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 18:38 UTCJob: ddbde09b